Neuroscience-Informed Psychoeducation for Recovery: A Program to Promote Metacognition in People With Substance Use Disorders
Basic and Clinical Neuroscience Journal · 01.09.2021 · 12 (5) · 597-606
DOI: 10.32598/bcn.2021.809.3 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic and Clinical Neuroscience Journal, online erschienen am 01.09.2021. Verfasst von Tara Rezapour und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cognitive Psychology, Institute for Cognitive Science Studies (ICSS), Tehran, Iran. Die Arbeit wurde bisher 23-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Introduction
A brief neuroscience-informed psychoeducation program (Neuroscience-Informed Psychoeducation for Recovery [NIPER]) was developed to promote awareness (metacognition) in the main cognitive domains affected by drug and alcohol use to increase willingness to invest time and effort in the brain and cognition recovery process. The primary aim of this pilot study was to determine the feasibility and acceptability of the NIPER program and its potential effectiveness in increasing metacognition, psychological wellbeing, and willingness for the brain and cognition recovery programs among patients with Substance Use Disorders (SUDs).
Methods
A total of 56 patients with SUDs were recruited from four outpatient treatment centers in Tehran City, Iran. They participated in four 90-min weekly sessions delivered adjunct to their routine treatment. The program’s effectiveness was measured in terms of metacognition and psychological wellbeing at baseline and the end of the program. The rate of adherence and participation and willingness to continue with brain and cognition recovery programs were measured as feasibility outcomes.
Results
A total of 51 participants completed the study. Compared to the baseline assessments, patients reported more problems in dimensions of attention, memory, inhibitory control, decision making, motor/speech, interoception, insight, and a higher level of psychological wellbeing (t=4.66; P
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Cognitive Psychology, Institute for Cognitive Science Studies (ICSS), Tehran, Iran.
- Department of Psychology, Faculty of Education and Psychology, Shahid Beheshti University, Tehran, Iran.
- Department of Sociology, Faculty of Social Science, University of Tehran, Tehran, Iran.
- Iranian National Center for Addiction Studies (INCAS), Tehran University of Medical Sciences, Tehran, Iran.
- Department of Educational Psychology, Faculty of Social Science, Islamic Azad University, Saveh, Iran.
- Department of Neuroscience and Addiction Studies, School of Advanced Technologies in Medicine, Tehran University of Medical Sciences, Tehran, Iran.
ORCID-Profile: Tara Rezapour, Mohammad Barzegari, Elham Sharifi, Nastaran Malmir, Mohammad Salehi, Alireza Noroozi, Hamed Ekhtiari
Zitieren
APA
Rezapour, T., Barzegari, M., Sharifi, E., Malmir, N., Ghiasvand, H., Salehi, M., Noroozi, A., & Ekhtiari, H. (2021). Neuroscience-Informed Psychoeducation for Recovery: A Program to Promote Metacognition in People With Substance Use Disorders. Basic and Clinical Neuroscience Journal, 12(5), 597-606. https://doi.org/10.32598/bcn.2021.809.3
Vancouver
Rezapour T, Barzegari M, Sharifi E, Malmir N, Ghiasvand H, Salehi M, et al. Neuroscience-Informed Psychoeducation for Recovery: A Program to Promote Metacognition in People With Substance Use Disorders. Basic and Clinical Neuroscience Journal. 2021;12(5):597-606. doi:10.32598/bcn.2021.809.3
BibTeX
@article{Rezapour2021,
author = {Rezapour, Tara and Barzegari, Mohammad and Sharifi, Elham and Malmir, Nastaran and Ghiasvand, Hamidreza and Salehi, Mohammad and Noroozi, Alireza and Ekhtiari, Hamed},
title = {Neuroscience-Informed Psychoeducation for Recovery: A Program to Promote Metacognition in People With Substance Use Disorders},
journal = {Basic and Clinical Neuroscience Journal},
year = {2021},
volume = {12},
number = {5},
pages = {597--606},
doi = {10.32598/bcn.2021.809.3}
}
EUVIMED